ASCO Warns Against Using Successful Ivermectin and Fenbendazole | Recommends Cancer Causing COVID-19 Vaccines | Pure Evil
William Makis | makisw.substack.com
MY RESPONSE:
- American Society of Clinical Oncology (ASCO) is lying to the public, to protect a collapsing $233 billion a year Cancer Drug Industry.
- There are now 7 Clinical Trials examining the use of Ivermectin in Cancer, one in California NCT05318469, and six in Florida including NCT07487805
- This makes Ivermectin one of the most exciting and researched modalities for use in cancer today, much more exciting than anything happening in mainstream Oncology
- There are 5 Clinical Trials examining the use of Mebendazole in Cancer (which is almost identical to Fenbendazole), including two by Johns Hopkins, and international centers in Sweden, Egypt and India
- Johns Hopkins obtained a patent for Mebendazole use in Glioblastoma in 2021, one of the most aggressive human cancers that mainstream Oncology hasn’t been able to help.
- Hundreds of thousands of cancer patients are using Ivermectin, Mebendazole and Fenbendazole safely and successfully all around the world, and these patients can be found in every Cancer Center in North America - and they are doing much better than their peers
- ASCO should be celebrating Ivermectin, Mebendazole and Fenbendazole, and encouraging the explosion of research that is happening.
- Instead, ASCO is shamelessly lying to cancer patients and staying unethical, idiotic things like: “websites, podcasts and social media accounts providing misinformation about the risks and benefits of these drugs can rapidly reach and capture patients when they are at their most vulnerable“
- Most of these cancer patients were sent home to die by their Oncologists, you ASCO con artists and frauds.
- These cancer patients are vulnerable because their mainstream Oncologist lied to them about their options, or told them they are out of options, which is never the case.
- ASCO has blood on its hands.
- In 2021, ASCO pushed cancer causing COVID-19 Vaccines on vulnerable cancer patients
- In 2024, ASCO issued a formal Clinical Practice Guideline, Vaccination of Adults With Cancer. It lists cancer causing COVID-19 vaccines among the seasonal vaccines patients with solid or hematologic cancers “should receive”.
- ASCO promoted cancer causing COVID-19 Vaccines for years, but now they advise patients who developed Turbo Cancer from these mRNA jabs and all other cancer patients not to pursue the benefits of Ivermectin, Mebendazole and Fenbendazole.
Original Article: https://makisw.substack.com/p/news-asco-warns-against-using-ivermectin
Comments ()